Previous 10 | Next 10 |
The Phase II clinical trial investigates Philogen's immunocytokines (i) L19IL2 (ii) L19TNF, and (iii) Nidlegy™ in combination with MSD’s anti-PD-1 therapy, KEYTRUDA ® (pembrolizumab) in stage III and IV unresectable melanoma patients who previously failed treatment with che...
Mumbai, India and Siena, Italy, 30 th May 2023 – Sun Pharmaceutical Industries Limited (Reuters: SUN.BO, Bloomberg: SUNP IN, NSE: SUNPHARMA, BSE: 524715 (together with its subsidiaries and/or associated companies, “Sun Pharma”)) and Philogen S.p....
New York, May 26, 2023 (GLOBE NEWSWIRE) -- PHI Group, Inc. (n/k/a Philux Global Group Inc., www.phiglobal.com , PHIL ), is pleased to announce that the Company has signed a Business Cooperation Agreement with SSE Group JSC, a Vietnamese joint stock company, to jointly cooperate in t...
Philog en Publishe s New Data on a Fibromun -based treatment combination in Science Translational Medicine in collaboration with the University Hospital Zürich L19TNF (also known as Fibromun ) is a n innovative immunothe...
Providing USD 500 Million in the First Phase and Additional Funds from Asset Management Contract Commitments to Complete the Investment Program New York, Feb. 27, 2023 (GLOBE NEWSWIRE) -- Philux Global Group, Inc. (a/k/a PHI Group, Inc.; www.philuxglobal.com , PHIL ...
New York, Feb. 15, 2023 (GLOBE NEWSWIRE) -- Philux Global Group, Inc. (a/k/a PHI Group, Inc.; www.philuxglobal.com , PHIL ), announced today that the Company has signed an agreement for comprehensive cooperation with Dr. Tri Viet Do, a German-trained expert in electromagnetic ene...
New York, Feb. 07, 2023 (GLOBE NEWSWIRE) -- Philux Global Group, Inc. (a/k/a PHI Group, Inc.; www.philuxglobal.com , PHIL ), announced today that Thanh Nam Long Co., Ltd., a Vietnamese construction and infrastructure development company, has signed an agreement with Philux G...
New York, Feb. 01, 2023 (GLOBE NEWSWIRE) -- PHI Group, Inc. (n/k/a Philux Global Group Inc., www.philuxglobal.com , PHIL ), a diversified holding company currently sponsoring PHILUX Global Funds, developing the Asia Diamond Exchange project (“ADE”), engaging in mer...
New York, Sept. 12, 2022 (GLOBE NEWSWIRE) -- PHI Group, Inc. (n/k/a Philux Global Group Inc., www.philuxglobal.com , PHIL ), a diversified holding company currently sponsoring PHILUX Global Funds (a group of Luxembourg bank funds), developing the Asia Diamond Exchange projec...
New York, Sept. 06, 2022 (GLOBE NEWSWIRE) -- PHI Group, Inc. (n/k/a Philux Global Group Inc., www.phiglobal.com , PHIL ), a diversified holding company currently sponsoring PHILUX Global Funds, developing the Asia Diamond Exchange project (“ADE”) in Vietnam, en...
News, Short Squeeze, Breakout and More Instantly...
Volcon Inc. (VLCN) is expected to report for Q4 2023 Tenaga Nasional Bhd ADR (TNABY) is expected to report for quarter end 2023-12-31 Hesai Group (HSAI) is expected to report for Q4 2023 Intrusion Inc. (INTZ) is expected to report $-0.14 for Q4 2023 Eliem Therapeutics Inc (ELYM) i...
Crescent Energy Company Class A (CRGY) is expected to report $0.21 for Q4 2023 ThredUp Inc. (TDUP) is expected to report $-0.13 for Q4 2023 Wright Investors` Service Holdings Inc (IWSH) is expected to report for Q4 2023 Bridgford Foods Corporation (BRID) is expected to report for Q1 2...
SUIC Worldwide Holdings Ltd (SUIC) is expected to report for Q4 2023 QuantaSing Group Limited (QSG) is expected to report $0.11 for Q2 2024 uniQure N.V. (QURE) is expected to report $-1.54 for Q4 2023 Albany International Corporation (AIN) is expected to report $0.84 for Q4 2023 I...